$18.18
1.20% today
Nasdaq, Feb 05, 04:20 pm CET
ISIN
US29772L1089
Symbol
ETON
Sector
Industry

Eton Pharmaceuticals, Inc. Stock price

$17.96
+5.80 47.70% 1M
+14.44 410.23% 6M
+4.64 34.83% YTD
+13.38 292.14% 1Y
+14.21 378.93% 3Y
+11.15 163.73% 5Y
+11.71 187.36% 10Y
Nasdaq, Closing price Tue, Feb 04 2025
+1.29 7.74%
ISIN
US29772L1089
Symbol
ETON
Sector
Industry

Key metrics

Market capitalization $478.36m
Enterprise Value $462.43m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 219.16
EV/Sales (TTM) EV/Sales 13.33
P/S ratio (TTM) P/S ratio 13.79
P/B ratio (TTM) P/B ratio 29.04
Revenue growth (TTM) Revenue growth 5.64%
Revenue (TTM) Revenue $34.68m
EBIT (operating result TTM) EBIT $-5.22m
Free Cash Flow (TTM) Free Cash Flow $2.11m
Cash position $20.26m
EPS (TTM) EPS $-0.21
P/E forward negative
P/S forward 12.62
EV/Sales forward 12.20
Short interest 0.83%
Show more

Is Eton Pharmaceuticals, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,821 stocks worldwide.

Eton Pharmaceuticals, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

3 Analysts have issued a Eton Pharmaceuticals, Inc. forecast:

3x Buy
100%

Analyst Opinions

3 Analysts have issued a Eton Pharmaceuticals, Inc. forecast:

Buy
100%

Financial data from Eton Pharmaceuticals, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
35 35
6% 6%
100%
- Direct Costs 14 14
56% 56%
41%
21 21
14% 14%
59%
- Selling and Administrative Expenses 20 20
10% 10%
56%
- Research and Development Expense 5.17 5.17
61% 61%
15%
-4.13 -4.13
251% 251%
-12%
- Depreciation and Amortization 1.09 1.09
24% 24%
3%
EBIT (Operating Income) EBIT -5.22 -5.22
380% 380%
-15%
Net Profit -5.48 -5.48
346% 346%
-16%

In millions USD.

Don't miss a Thing! We will send you all news about Eton Pharmaceuticals, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Eton Pharmaceuticals, Inc. Stock News

Neutral
GlobeNewsWire
about one month ago
DEER PARK, Ill., Jan. 03, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it has acquired Galzin® (zinc acetate).
Neutral
GlobeNewsWire
about 2 months ago
DEER PARK, Ill., Dec. 20, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or “the Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it has completed its previously announced asset purchase of Increlex® (mecasermin injection) from Ipsen S.A. (“Ipsen”). Increlex® is a biologic prod...
Neutral
GlobeNewsWire
2 months ago
DEER PARK, Ill., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced the appointment of Ipek Erdogan-Trinkaus as Chief Commercial Officer (CCO).
More Eton Pharmaceuticals, Inc. News

Company Profile

Eton Pharmaceuticals, Inc. engages in the development and commercialization of prescription drug products. It focuses on product candidates that are liquid in formulation, including injectables, oral liquids and ophthalmics. The company was founded in April 2017 and is headquartered in Deer Park, IL.

Head office United States
CEO Sean Brynjelsen
Employees 30
Founded 2017
Website www.etonpharma.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today